Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease

Torres, D. M., Williams, C. D. & Harrison, S. A. Features, diagnosis and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 10, 837–858 (2012). 10.1016/j.cgh.2012.03.011

[2]

Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836–1846 (2010). 10.1002/hep.24001

[3]

Abu-Shanab, A. & Quigley, E. M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7, 691–701 (2010). 10.1038/nrgastro.2010.172

[4]

Moschen, A. R., Kaser, S. & Tilg, H. Non-alcoholic steatohepatitis: a microbiota-driven disease. Trends Endocrinol Metab 24, 537–545 (2013). 10.1016/j.tem.2013.05.009

[5]

An obesity-associated gut microbiome with increased capacity for energy harvest

Peter J. Turnbaugh, Ruth E. Ley, Michael A. Mahowald et al.

Nature 2006 10.1038/nature05414

[6]

Le Roy, T. et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62, 1787–1794 (2013). 10.1136/gutjnl-2012-303816

[7]

Interactions Between the Microbiota and the Immune System

Lora V. Hooper, Dan R. Littman, Andrew J. Macpherson

Science 2012 10.1126/science.1223490

[8]

Su, L. et al. Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis. Chin Med J (Engl) 125, 306–311 (2012).

[9]

Raman, M. et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 11, 868–875 e861–863 (2013). 10.1016/j.cgh.2013.02.015

[10]

Mouzaki, M. et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58, 120–127 (2013). 10.1002/hep.26319

[11]

Zhu, L. et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57, 601–609 (2013). 10.1002/hep.26093

[12]

Son, G., Kremer, M. & Hines, I. N. Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract 2010, 1–13 (2010). 10.1155/2010/453563

[13]

Compare, D. et al. Gut--liver axis: the impact of gut microbiota on non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 22, 471–476 (2012). 10.1016/j.numecd.2012.02.007

[14]

Miele, L. et al. Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Curr Pharm Des 19, 5314–5324 (2013). 10.2174/1381612811319290011

[15]

Fallucca, F., Porrata, C., Fallucca, S. & Pianesi, M. Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet. Diabetes Metab Res Rev 30 Suppl 1, 48–54 (2014). 10.1002/dmrr.2518

[16]

Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103 (2009). 10.1136/gut.2008.165886

[17]

Cani, P. D., Osto, M., Geurts, L. & Everard, A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3, 279–288 (2012). 10.4161/gmic.19625

[18]

Small, C. L., Reid-Yu, S. A., McPhee, J. B. & Coombes, B. K. Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun 4, 1957 (2013). 10.1038/ncomms2957

[19]

Cuevas-Ramos, G. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 107, 11537–11542 (2010). 10.1073/pnas.1001261107

[20]

Prorok-Hamon, M. et al. Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut 63, 761–770 (2014). 10.1136/gutjnl-2013-304739

[21]

Al-Jashamy, K., Murad, A., Zeehaida, M., Rohaini, M. & Hasnan, J. Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. Asian Pac J Cancer Prev 11, 1765–1768 (2010).

[22]

Cucchiara, S., Iebba, V., Conte, M. P. & Schippa, S. The microbiota in inflammatory bowel disease in different age groups. Dig Dis 27, 252–258 (2009). 10.1159/000228558

[23]

Scheppach, W. & Weiler, F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care 7, 563–567 (2004). 10.1097/00075197-200409000-00009

[24]

Kles, K. A. & Chang, E. B. Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma and failure. Gastroenterology 130, S100–105 (2006). 10.1053/j.gastro.2005.11.048

[25]

Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis

Harry J. Flint, Edward A. Bayer, Marco T. Rincon et al.

Nature Reviews Microbiology 2008 10.1038/nrmicro1817

[26]

Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011). 10.1126/science.1208344

[27]

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

Carlotta De Filippo, Duccio Cavalieri, Monica Di Paola et al.

Proceedings of the National Academy of Sciences 2010 10.1073/pnas.1005963107

[28]

Kim, C. S. et al. Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity (Silver Spring) 16, 1261–1269 (2008). 10.1038/oby.2008.55

[29]

Tanaka, S. et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord 17, 631–636 (1993).

[30]

Tanaka, S., Isoda, F., Ishihara, Y., Kimura, M. & Yamakawa, T. T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin Endocrinol (Oxf) 54, 347–354 (2001).

[31]

Norimatsu, M. et al. Lipopolysaccharide-induced apoptosis in swine lymphocytes in vivo. Infect Immun 63, 1122–1126 (1995). 10.1128/iai.63.3.1122-1126.1995

[32]

Nielsen, J. S. et al. Rough-Form-Lipopolysaccharide Increase Apoptosis in Human CD4(+) and CD8(+) T-Lymphocytes. Scand J Immunol 75, 193–202 (2012). 10.1111/j.1365-3083.2011.02613.x

[33]

Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases and American College of Gastroenterology. Gastroenterology 142, 1592–1609 (2012). 10.1053/j.gastro.2012.04.001

[34]

Cong, X. et al. Activation of transient receptor potential vanilloid subtype 1 increases expression and permeability of tight junction in normal and hyposecretory submandibular gland. Lab Invest 92, 753–768 (2012). 10.1038/labinvest.2012.12

Cited By

515

Gut microbiota and associated metabolites: key players in high-fat diet-induced chronic diseases

Wei Du, Zhen-Ping Zou · 2025

Gut Microbes

Oral exposure to PLA microplastics induces time-dependent nanotoxicity via the gut-liver axis

Jinghan Fan, Yijiao Qu · 2025

Journal of Hazardous Materials

The gut microbiome modulates associations between adherence to a Mediterranean-style diet, abdominal adiposity, and C-reactive protein in population-level analysis

Amy Jennings, Tilman Kühn · 2024

The American Journal of Clinical Nu...

Composition of gut microbiota and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

Xin Su, Shiyun Chen · 2023

Obesity Reviews

Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors’ Combination

Sergio Quesada-Vázquez, Caitlin Bone · 2022

International Journal of Molecular...

Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits

Moritz Peiseler, Robert Schwabe · 2022

Journal of Hepatology

Changes and significance of gut microbiota in children with focal epilepsy before and after treatment

Changci Zhou, Shuaizheng Gong · 2022

Frontiers in Cellular and Infection...

Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents

Daisuke Tokuhara · 2021

Frontiers in Nutrition

Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease

Chyntia Olivia Maurine Jasirwan, Akhmadu MURADI · 2021

Bioscience of Microbiota, Food and...

Chemically or surgically induced thyroid dysfunction altered gut microbiota in rat models

Na Rae Shin, Shambhunath Bose · 2020

The FASEB Journal

Homeostasis and dysbiosis of the gut microbiome in health and disease

Bhabatosh Das, G Balakrish Nair · 2019

Journal of Biosciences

Distinct Gut Microbiota Composition and Functional Category in Children With Cerebral Palsy and Epilepsy

Congfu Huang, Yinhu Li · 2019

Frontiers in Pediatrics

Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis

Stuart Astbury, Edmond Atallah · 2019

Gut Microbes

Triggering and resolution of inflammation in NASH

Susanne Schuster, Daniel Cabrera · 2018

Nature Reviews Gastroenterology &am...

The gut–liver axis and the intersection with the microbiome

Anupriya Tripathi, Justine Debelius · 2018

Nature Reviews Gastroenterology &am...

Microbiome-Modulated Metabolites at the Interface of Host Immunity

Eran Blacher, Maayan Levy · 2017

The Journal of Immunology

Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet

Marco Candela, Elena Biagi · 2016

British Journal of Nutrition

The gut microbiota: A treasure for human health

Daotong Li, Pan Wang · 2016

Biotechnology Advances

Metrics

515

Citations

34

References

Details

Published: Feb 03, 2015
Vol/Issue: 5(1)
License: View

Authors

Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, 18 Shilongshan Road, Hangzhou 310024, Zhejiang Province, China.; School of Life Sciences, Westlake University, 18 Shilongshan Road, Hangzhou 310024, Zhejiang Province, China.

Nanchang University

Cite This Article

Weiwei Jiang, Na Wu, Xuemei Wang, et al. (2015). Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Scientific Reports, 5(1). https://doi.org/10.1038/srep08096

Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease

You May Also Like